PlainRecalls
FDA Devices Moderate Class II Terminated

The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.

Reported: August 7, 2013 Initiated: February 4, 2013 #Z-1847-2013

Product Description

The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.

Reason for Recall

The devices secondary audio signal fails to activate.

Details

Recalling Firm
Hospira Inc.
Units Affected
2,791 units
Distribution
US Distribution including the states of AL, CA, CT, DE, FL, HI, IA, IL, IN, LA, MA, MD, ME, MI, MN, NC, NJ, NY, PA, SD, TX and WA.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.. Recalled by Hospira Inc.. Units affected: 2,791 units.
Why was this product recalled?
The devices secondary audio signal fails to activate.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 7, 2013. Severity: Moderate. Recall number: Z-1847-2013.